- ►annals.org AD Desai, S Chun, RJ Sung - Annals of internal medicine, 1997 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To review the electropharmacology, clinical applications, side ... Cited by 52 - Related articles - BL Direct - All 5 versions
C Cardiol - Clin. Cardiol, 1996 - interscience.wiley.com Background: Paroxysmal atrial fibrillation (PAF) and paroxysmal supraventricular
tachycardia (PSVT) leading to hemodynamic compromise are among the most common
reasons for admission to the coronary care unit (CCU) and need prompt and ... Cited by 37 - Related articles - BL Direct - All 3 versions
SH Hohnloser, M Zabel, M Zehender, T … - Journal of cardiovascular pharmacology - journals.lww.com Summary: Intravenously administered amiodarone exerts substantial antiarrhythmic
activity that is based on several different electrophysiologic mechanisms. Of
these, the most important consists of an antitachycardic effect together ... Cited by 13 - Related articles - All 3 versions
SJ Evans, M Myers, C Zaher, J Simonson, P … - Journal of the American College of Cardiology, 1992 - Am Coll Cardio Found Search. ... Cited by 17 - Related articles - All 3 versions
KL Mount, KK Pickworth - Journal of Pharmacy Practice, 2002 - jpp.sagepub.com Purpose: To review the literature to define the efficacy of in- travenous (IV)
amiodarone in the treatment of atrial fibrilla- tion in the nonsurgical patient.
Method: A MEDLINE search was conducted using the key words “intravenous ... Related articles - BL Direct
- ►ahajournals.org GV Naccarelli, S Jalal - Circulation, 1995 - Am Heart Assoc Two timely articles published in this volume of Circulation by Scheinman et al 1
and Kowey et al 2 present data from recently completed trials confirming the
efficacy of intravenous amiodarone in life-threatening ventricular ... Cited by 28 - Related articles - BL Direct - All 4 versions
G Vietti-Ramus, F Veglio, U Marchisio, P … - International journal of cardiology, 1992 - ncbi.nlm.nih.gov The safety and efficacy of short intravenous therapy with amiodarone were
evaluated in 44 patients (24 males, 20 females), aged 21-84 years, with
supraventricular tachyarrhythmias newly arisen in less than 24 hours. The ... Cited by 29 - Related articles - All 2 versions
- ►bmj.com Y Kreiss, Y Sidi, H Gur - British Medical Journal, 1999 - pmj.bmj.com We examined the efficacy and safety of intravenous amiodarone in 20 unselected
patients with recent-onset atrial fibrillation who were admitted to a general
internal medicine department during a 6-month period. The treatment ... Cited by 29 - Related articles - BL Direct - All 6 versions
TAO Najjar - European journal of drug metabolism and …, 2001 - 万方数据资源系统 The pharmacokinetics of amiodarone was studied after single and multiple dosing
in two groups of male Wistar and Albino rats. The first group (40 rats) received
a single intraperitoneal (ip) dose of amiodarone (100 mg/kg) and 4 rats ... Cited by 9 - Related articles - BL Direct - All 5 versions
A Capucci, D Pozzetti, GQ Villani - Ital Heart J, 2001 - giornale-italiano-cardiologia.it L'amiodarone è un farmaco di classe III che presenta anche caratteristiche
elettrofi- siologiche di classe I (blocco dei canali del sodio a frequenza
cardiaca elevata), classe II (attività antisimpatica non competitiva) e ... Related articles - View as HTML - All 2 versions
